Drug Trial Radar · NCT06775730
A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
Last checked: Nov 20, 2026Latest source record: May 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Dec 30, 2024
Primary completion
Apr 3, 2025
Study completion Apr 3, 2025
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Jan 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine the potential for drug-drug interactions.
Conditions
- Healthy Adult Female Participants
Interventions
EnsitrelvirDrug
Ensitrelvir will be administered per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Plasma Concentration (Cmax) of Ethinyl Estradiol (EE)Time frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
- Cmax of Drospirenone (DRSP)Time frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
- Time to Reach Cmax (Tmax) of EETime frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
- Tmax of DRSPTime frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
- Area Under the Plasma Concentration-time Curve Over the Dosing Interval (AUC0-τ) of EETime frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
- AUC0-τ of DRSPTime frame: Predose and up to 24 hours postdose on Days 19, 20, and 24
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Early Phase Clinical Unit Los Angeles
Glendale, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.